Quoin Pharmaceuticals Statistics
Total Valuation
QNRX has a market cap or net worth of $5.10 million. The enterprise value is -$3.49 million.
Market Cap | 5.10M |
Enterprise Value | -3.49M |
Important Dates
The last earnings date was Tuesday, May 13, 2025, before market open.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
QNRX has 588,166 shares outstanding. The number of shares has increased by 633.25% in one year.
Current Share Class | n/a |
Shares Outstanding | 588,166 |
Shares Change (YoY) | +633.25% |
Shares Change (QoQ) | +213.72% |
Owned by Insiders (%) | 7.08% |
Owned by Institutions (%) | 1.84% |
Float | 515,649 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.89 |
P/TBV Ratio | 0.97 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.47.
Current Ratio | 2.57 |
Quick Ratio | 2.38 |
Debt / Equity | 0.47 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -138.82% and return on invested capital (ROIC) is -65.02%.
Return on Equity (ROE) | -138.82% |
Return on Assets (ROA) | -47.40% |
Return on Invested Capital (ROIC) | -65.02% |
Return on Capital Employed (ROCE) | -136.15% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.09M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.46% in the last 52 weeks. The beta is 1.78, so QNRX's price volatility has been higher than the market average.
Beta (5Y) | 1.78 |
52-Week Price Change | -64.46% |
50-Day Moving Average | 7.44 |
200-Day Moving Average | 16.21 |
Relative Strength Index (RSI) | 60.09 |
Average Volume (20 Days) | 523,509 |
Short Selling Information
Short Interest | 225,364 |
Short Previous Month | 19,180 |
Short % of Shares Out | 38.32% |
Short % of Float | 43.70% |
Short Ratio (days to cover) | 0.47 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -11.03M |
Pretax Income | -8.28M |
Net Income | -10.45M |
EBITDA | -10.93M |
EBIT | -11.03M |
Earnings Per Share (EPS) | -$39.35 |
Balance Sheet
The company has $11.55 million in cash and $2.77 million in debt, giving a net cash position of $8.78 million or $14.93 per share.
Cash & Cash Equivalents | 11.55M |
Total Debt | 2.77M |
Net Cash | 8.78M |
Net Cash Per Share | $14.93 |
Equity (Book Value) | 5.93M |
Book Value Per Share | 10.08 |
Working Capital | 7.64M |
Cash Flow
Operating Cash Flow | -9.02M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
QNRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -633.25% |
Shareholder Yield | -633.25% |
Earnings Yield | -197.36% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on April 9, 2025. It was a reverse split with a ratio of 0.0285714:1.
Last Split Date | Apr 9, 2025 |
Split Type | Reverse |
Split Ratio | 0.0285714:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |